Home › Funds › Fideuram Asset Management (Ireland) dac › RPRX

Fideuram Asset Management (Ireland) dac position in RPRX

ROYALTY PHARMA PLC · Health Care

Fideuram Asset Management (Ireland) dac reported holding 614,987 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$36.3M, representing 0.79% of its reported portfolio and ranking #14 among its reported holdings. Fideuram Asset Management (Ireland) dac has disclosed RPRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)614.99K sh
Reported value held$36.26M
Portfolio Weight0.79%
First reportedQ4 2025
Last changeAdd
Updated2026-10-29

Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR

How Fideuram Asset Management (Ireland) dac's RPRX position evolved

Fideuram Asset Management (Ireland) dac first disclosed a stake in RPRX in Q4 2025 at 10,795 shares (US$413K). The position peaked in Q3 2026 at 614,987 shares, worth US$36.3M. Across 4 filings, Fideuram Asset Management (Ireland) dac increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 614,987 shares valued at US$36.3M — an increase of 408,199 shares quarter over quarter.. Notable position changes include a 1596% increase in Q2 2026 (shares rose 4% over the following quarter), a 197% increase in Q3 2026 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.79K $412.99K New
Q1 2026 12.19K $516.64K Add
Q2 2026 206.79K $10.24M Add
Q3 2026 614.99K $36.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Fideuram Asset Management (Ireland) dac held RPRX?

Fideuram Asset Management (Ireland) dac has disclosed RPRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Fideuram Asset Management (Ireland) dac's current position in RPRX?

As of Q3 2026, Fideuram Asset Management (Ireland) dac holds 614.99K shares of RPRX (ROYALTY PHARMA PLC), valued at $36.26M, representing 0.79% of its reported portfolio and ranking #14.

Has Fideuram Asset Management (Ireland) dac been buying or selling RPRX?

In the latest 13F filing (Q3 2026), Fideuram Asset Management (Ireland) dac increased its position in RPRX. The position peaked in Q3 2026 at 614.99K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.